ZOTA

Zota Health Care LImited

Pharmaceutical and healthcare company with retail pharmacy and IT services

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹1409.30
Market cap
4,879 Cr
Stock P/E
Loss (TTM EPS ₹-30.58)
P/B
7.04
Dividend yield
0.1%
ROE (FY26)
-10.6%
ROCE (FY26)
-8.6%
Operating margin (FY26)
-11.9%
Debt / equity (FY26)
0.04
OCF / EBITDA (FY26)
-455.4%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Zota Health Care runs Davaindia, a chain of 2,825 stores (June 2026) selling quality generic medicines at affordable prices across India, and also makes and sells pharmaceutical products in India and for export.

Company snapshot

60thBy market cap

Ranked among 119 companies in Pharmaceuticals.

What we see

Positives
  • ✓Debt-to-equity of 0.04x — the company is largely funded by its own money, not borrowed funds.
Concerns
  • ✗Net margin is negative — the company is spending more than it earns right now.
2 more signals from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales45 Cr47 Cr50 Cr56 Cr67 Cr72 Cr97 Cr104 Cr129 Cr143 Cr163 Cr174 Cr
Operating expenses (approx.)41 Cr44 Cr51 Cr58 Cr68 Cr78 Cr95 Cr100 Cr123 Cr143 Cr154 Cr185 Cr
EBITDA4 Cr3 Cr-1 Cr-1 Cr-0.87 Cr-6 Cr2 Cr4 Cr6 Cr-0.44 Cr9 Cr-12 Cr
OPM %9.8%7.1%-3.0%-2.2%-1.3%-8.4%2.5%3.8%4.9%-0.3%5.3%-6.7%
Other income0.40 Cr0.15 Cr0.46 Cr0.02 Cr0.54 Cr0.51 Cr1 Cr0.88 Cr2 Cr2 Cr3 Cr2 Cr
Interest1 Cr1 Cr2 Cr3 Cr3 Cr2 Cr3 Cr3 Cr4 Cr5 Cr5 Cr6 Cr
Depreciation5 Cr5 Cr7 Cr8 Cr10 Cr11 Cr14 Cr15 Cr19 Cr22 Cr27 Cr28 Cr
Profit before tax-1 Cr-3 Cr-10 Cr-12 Cr-13 Cr-18 Cr-14 Cr-13 Cr-14 Cr-26 Cr-26 Cr-44 Cr
Tax %-48.8%-7.5%27.2%-4.6%4.0%-2.5%9.9%-5.3%-12.6%-14.2%45.3%-0.7%
Net profit-2 Cr-3 Cr-7 Cr-13 Cr-12 Cr-19 Cr-13 Cr-14 Cr-16 Cr-30 Cr-14 Cr-44 Cr
EPS (₹)₹-0.64₹-1.14₹-2.68₹-4.80₹-4.57₹-6.80₹-4.57₹-4.92₹-5.26₹-9.44₹-4.13₹-12.58

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales86 Cr95 Cr107 Cr131 Cr140 Cr180 Cr293 Cr539 CrSign in free for the trailing twelve months
Operating expenses (approx.)78 Cr91 Cr106 Cr116 Cr133 Cr173 Cr299 Cr520 CrSign in free for the trailing twelve months
EBITDA8 Cr5 Cr0.62 Cr15 Cr7 Cr8 Cr-6 Cr19 CrSign in free for the trailing twelve months
OPM %9.0%4.7%0.6%11.3%5.2%4.2%-2.0%3.4%Sign in free for the trailing twelve months
Other income2 Cr2 Cr1 Cr2 Cr2 Cr1 Cr2 Cr7 CrSign in free for the trailing twelve months
Interest0.04 Cr0.07 Cr0.11 Cr0.32 Cr3 Cr5 Cr11 Cr17 CrSign in free for the trailing twelve months
Depreciation1 Cr2 Cr3 Cr4 Cr12 Cr20 Cr43 Cr82 CrSign in free for the trailing twelve months
Profit before tax8 Cr4 Cr-0.37 Cr12 Cr-5 Cr-16 Cr-58 Cr-80 CrSign in free for the trailing twelve months
Tax %29.4%29.0%42.8%28.4%-23.1%11.2%1.6%7.2%Sign in free for the trailing twelve months
Net profit6 Cr3 Cr-0.21 Cr9 Cr-6 Cr-14 Cr-57 Cr-74 CrSign in free for the trailing twelve months
EPS (₹)₹2.26₹1.12₹-0.09₹3.58₹-2.29₹-5.59₹-20.68₹-22.46Sign in free for the trailing twelve months
Dividend payout %———28.2%————Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital18 Cr25 Cr25 Cr25 Cr25 Cr26 Cr29 Cr35 Cr
Reserves51 Cr44 Cr42 Cr64 Cr55 Cr64 Cr195 Cr659 Cr
Borrowings0 Cr0 Cr——9 Cr15 Cr6 Cr29 Cr
Other liabilities21 Cr20 Cr19 Cr49 Cr69 Cr124 Cr206 Cr406 Cr
Total liabilities90 Cr88 Cr85 Cr139 Cr158 Cr228 Cr439 Cr1,131 Cr
Fixed assets (net)8 Cr8 Cr8 Cr9 Cr15 Cr24 Cr56 Cr140 Cr
CWIP0.26 Cr0 Cr0.04 Cr—3 Cr5 Cr6 Cr2 Cr
Investments16 Cr14 Cr10 Cr33 Cr8 Cr5 Cr54 Cr264 Cr
Loans & advances————7 Cr17 Cr17 Cr37 Cr
Inventories33 Cr25 Cr28 Cr29 Cr42 Cr54 Cr106 Cr193 Cr
Trade receivables22 Cr29 Cr29 Cr36 Cr28 Cr27 Cr41 Cr74 Cr
Cash & bank0.02 Cr0.01 Cr0.02 Cr0.04 Cr0.09 Cr0.68 Cr2 Cr8 Cr
Other assets11 Cr12 Cr11 Cr32 Cr56 Cr97 Cr158 Cr414 Cr
Total assets90 Cr88 Cr85 Cr139 Cr158 Cr228 Cr439 Cr1,131 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity-3 Cr6 Cr-0.89 Cr13 Cr-2 Cr-6 Cr-50 Cr-84 Cr
Cash from investing9 Cr-4 Cr4 Cr-27 Cr15 Cr-13 Cr-92 Cr-314 Cr
Cash from financing-6 Cr-3 Cr-2 Cr14 Cr-14 Cr19 Cr145 Cr490 Cr
Net cash flow-0.77 Cr-0.86 Cr0.51 Cr0.95 Cr-1 Cr-0.11 Cr3 Cr92 Cr
Free cash flow (OCF − Capex)-6 Cr-0.63 Cr-3 Cr10 Cr-15 Cr-6 Cr-50 Cr-84 Cr

Ratios

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %11.5%5.7%-0.4%14.2%-2.4%-10.9%-20.1%-8.6%
ROE %8.0%4.0%-0.3%9.9%-7.2%-15.9%-24.8%-10.6%
Debtor days941129810172555050
Inventory days1028709508528873153623714015
Days payable5114202813415539609512180
Cash conversion cycle61140232528839363114701885
OCF / EBITDA %-41.9%122.8%n.m.90.1%-27.3%-79.2%—-455.4%
OCF / EBITDA % (3 years)——10.9%90.2%45.9%18.0%n.m.n.m.
Debt / equity0.000.00——0.110.160.030.04
Current ratio3.153.173.362.142.081.511.831.93
Net debt / EBITDA-0.0028———1.201.85—1.13